|
24
|
107
|
8uq4E |
Structure of human ryr2-s2808d in the subprimed state in the presence of h2o2/noc-12/gsh |
|
21
|
107
|
8uq2E |
Structure of human ryr2-s2808d in the subprimed state |
|
62
|
208
|
8bjdA |
Full length structure of lpmip with bound inhibitor jk095 |
|
37
|
133
|
8bjeA |
A structure of the truncated lpmip with bound inhibitor jk236. |
|
60
|
205
|
8bjcB |
Full length structure of the apo-state lpmip. |
|
24
|
107
|
8pdfA |
Fkbp12 in complex with protac 6a2 |
|
23
|
120
|
8pc2G |
Seldeg51 in complex with fkbp51fk1 domain and pvhl:elob:eloc |
|
131
|
409
|
8ffwD |
Cryo-em structure of the gr-hsp90-fkbp51 complex |
|
133
|
409
|
8ffvD |
Cryo-em structure of the gr-hsp90-fkbp52 complex |
|
52
|
164
|
8ejxA |
Crystal structure of human cyclophilin d (cypd) with in complex with the covalently bound ebselen inhibitor |
|
50
|
164
|
8g9pC |
Tricomplex of rmc-4998, kras g12c, and cypa |
|
52
|
164
|
8g9qD |
Tricomplex of compound-1, kras g12c, and cypa |
|
25
|
107
|
8ppzA |
Co-crystal structure of fkbp12, compound 7 and the frb fragment of mtor |
|
20
|
149
|
8g01C |
Yes complex - e. coli mray, protein e id21, e. coli slyd |
|
185
|
795
|
8jcw2 |
Cryo-em structure of mglu2-mglu3 heterodimer in presence of ly341495 and nam563 (dimerization mode i) |
|
158
|
795
|
8jd12 |
Cryo-em structure of mglu2-mglu3 heterodimer in rco state |
|
188
|
798
|
8jd42 |
Cryo-em structure of g protein-free mglu2-mglu4 heterodimer in acc state |
|
185
|
797
|
8jd02 |
Cryo-em structure of mglu2-mglu3 heterodimer in presence of nam563 |
|
184
|
796
|
8jcz2 |
Cryo-em structure of mglu2-mglu3 heterodimer in presence of ly341495, nam563, and ly2389575 (dimerization mode iii) |
|
185
|
795
|
8jcx2 |
Cryo-em structure of mglu2-mglu3 heterodimer in presence of ly341495 and nam563 (dimerization mode ii) |
|
196
|
796
|
8jcy2 |
Cryo-em structure of mglu2-mglu3 heterodimer in presence of ly341495, nam563, and ly2389575 (dimerization mode i) |
|
186
|
795
|
8jd22 |
Cryo-em structure of g protein-free mglu2-mglu3 heterodimer in acc state |
|
185
|
797
|
8jcv2 |
Cryo-em structure of mglu2-mglu3 heterodimer in presence of ly341495 (dimerization mode ii) |
|
193
|
798
|
8jcu2 |
Cryo-em structure of mglu2-mglu3 heterodimer in presence of ly341495 (dimerization mode i) |
|
0
|
4
|
8c3cB |
14-3-3 sigma with pin1 binding site ps72 and bound fusicoccin a |
|
16
|
107
|
8dujB |
Global map in c1 of ryr1 particles in complex with imperacalcin |
|
9
|
107
|
8dveB |
Ryr1 in presence of ipca-t26e phosphomimetic and activating ligands |
|
17
|
107
|
8setE |
Cryo-em structure of ryr1 + camp |
|
19
|
107
|
8sepE |
Cryo-em structure of ryr1 + adp |
|
15
|
107
|
8seqE |
Cryo-em structure of ryr1 + amp |
|
15
|
107
|
8senE |
Cryo-em structure of ryr1 |
|
18
|
107
|
8serE |
Cryo-em structure of ryr1 + adenosine |
|
18
|
107
|
8sesE |
Cryo-em structure of ryr1 + adenine |
|
17
|
107
|
8seoE |
Cryo-em structure of ryr1 + atp-gamma-s |
|
30
|
128
|
8ccdA |
The fk1 domain of fkbp51 in complex with 2-(3-((r)-1-(((s)-1-((s)-2-(5-chlorothiophen-2-yl)-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carbonyl)oxy)-3-(3,4-dimethoxyphenyl)propyl)phenoxy)acetic acid |
|
30
|
128
|
8cccA |
The fk1 domain of fkbp51 in complex with 2-(3-((r)-1-(((s)-1-((s)-2-(5-chlorothiophen-2-yl)propanoyl)piperidine-2-carbonyl)oxy)-3-(3,4-dimethoxyphenyl)propyl)phenoxy)acetic acid |
|
28
|
128
|
8cchA |
The fk1 domain of fkbp51 in complex with 2-(3-((1r)-1-(((2s)-1-(2-cyclohexyl-2-(thiophen-2-yl)acetyl)piperidine-2-carbonyl)oxy)-3-(3,4-dimethoxyphenyl)propyl)phenoxy)acetic acid |
|
29
|
127
|
8cceA |
The fk1 domain of fkbp51 in complex with 2-(3-((r)-1-(((s)-1-((s)-2-(5-chlorothiophen-2-yl)butanoyl)piperidine-2-carbonyl)oxy)-3-(3,4-dimethoxyphenyl)propyl)phenoxy)acetic acid |
|
32
|
127
|
8ccgA |
The fk1 domain of fkbp51 in complex with (2r,5s,12s)-12-(thiophen-2-yl)-2-[2-(3,4-dimethoxyphenyl)ethyl]-15,15-dimethyl-3,19-dioxa-10,13,16-triazatricyclo[18.3.1.0^5,^10]tetracosa-1(24),20,22-triene-4,11,14,17-tetrone |
|
30
|
128
|
8ccfA |
The fk1 domain of fkbp51 in complex with 2-(3-((r)-1-(((s)-1-((s)-2-(5-chlorothiophen-2-yl)pent-4-enoyl)piperidine-2-carbonyl)oxy)-3-(3,4-dimethoxyphenyl)propyl)phenoxy)acetic acid |
|
27
|
128
|
8ccbA |
The fk1 domain of fkbp51 in complex with 2-(3-((1r)-1-(((2s)-1-(2-(5-chlorothiophen-2-yl)-2-cyclohexylacetyl)piperidine-2-carbonyl)oxy)-3-(3,4-dimethoxyphenyl)propyl)phenoxy)acetic acid |
|
30
|
128
|
8ccaA |
The fk1 domain of fkbp51 in complex with safit1 |
|
52
|
164
|
7zdnA |
Human cyclophilin d in complex with fragment |
|
53
|
164
|
7r2jA |
Human cyclophilin d in complex with n-(4-aminophenyl)-7-methyl-2-oxo-1h,2h-pyrazolo[1,5-a]pyrimidine-6-carboxamide |
|
47
|
164
|
7r2iA |
Human cyclophilin d in complex with fragment |
|
49
|
164
|
7r2hA |
0.79a resolution structure of dmso bound cyclophilin d |
|
50
|
164
|
7r2lA |
Human cyclophilin d in complex with n-(4-aminophenyl)-7-methyl-2-oxo-1h,2h-pyrazolo[1,5-a]pyrimidine-6-carboxamide |
|
62
|
199
|
8b58A |
Crystal structure of cyclophilin tgcyp23 from toxoplasma gondii in complex with cyclosporin a |
|
30
|
163
|
7upnA |
Maedi visna virus vif in complex with cypa and e3 ubiquitin ligase |
|
23
|
107
|
8er6A |
Fkbp12-frb in complex with compound 11 |
